期刊文献+

外周血C3,C4与慢性荨麻疹患者病情的相关性 被引量:11

Investigate Chronic Urticaria Patient’s Condition Correlating to C3, C4 of Peripheral Blood
下载PDF
导出
摘要 目的探讨慢性荨麻疹(chronicurticaria,CU)患者外周血C3,C4水平与病情的相关性。方法采用免疫比浊法检测19例急性荨麻疹(acuteurticaria,AU)、146例CU患者的外周血C3,C4及IgG水平,并以20例健康人为对照。并通过荨麻疹活动评分(UAS)对165例荨麻疹患者的病情进行评分。结果 AU,CU患者外周血的C3,C4及IgG水平差异均无统计学意义(P均>0.05)。男女性CU患者外周血的C3,C4及IgG水平差异均无统计学意义(P均>0.05)。32例CU患者IgG水平高于正常值(IgG>17g/L),与C3,C4水平呈负相关(P<0.05)。UAS与荨麻疹外周血的C3,C4及IgG水平相关性差,差异无统计学意义(P均>0.05),但与IgG水平升高CU患者的C3,C4水平呈负相关,差异有统计学意义(P<0.05)。结论外周血C3,C4水平可以反应IgG水平升高的CU患者的病情。 Objective To investigate the expression of C3, C4 and lgG in peripheral blood of patients with chronic urti- caria(CU) and its eorrelationship with CU patients' severity. Methods The expression of C3, C4 amt IgG was measured by Immune Turbidimetry in 19 patients with acute urticaria(AU) , 146 patients with CU and 20 normal controls. The severity of 165 patients with uriearia was evaluated by Urticaria Activity Score (UAS). Results There were no statistically difference in the expression of C3, C4 and lgG between AU and CU patients (P 〉 0.05 ) , between male and female CU patients respectively( P 〉 0.05 ). The expression of IgG was higher than normal control( IgG 〉 17g/L) in 32 CU patients, and showed negative correlation with the expression of C3 and C4 (P 〈 0.05 ). UAS was poor relation to the expression of C3, C4 and IgG in urticaria patient's peripheral blood, but was negative con'elation to the levels of C3, C4 in CU patients whose expression of lgG was higher than normal control( P 〈 0.05 ). Conclusion The expression of C3, C4 could respond to the severity of CU patients whose expression of IgG is higher than normal control.
出处 《中国皮肤性病学杂志》 CAS 北大核心 2013年第1期26-28,共3页 The Chinese Journal of Dermatovenereology
关键词 慢性荨麻疹(CU) C3 C4 荨麻疹活动评分(UAS) Chronic urticaria(CU) C3 C4 Urticaria activity score (UAS)
  • 相关文献

参考文献13

  • 1刘辅仁主编..实用皮肤科学 第3版[M].北京:人民卫生出版社,2005:1183.
  • 2Zuberbier T, Asero R, Bindslev-Jensen C, et al. EAACI/GA(2) LEN/ EDF/WAO guideline : definition, classification anddiagnosis of urticaria[J]. Allergy, 2009, 64(10) :1417 - 1426. 被引量:1
  • 3Greaves M. Chronic urticaria[J]. J Allergy Clin Immunol, 2000,105 (4) :664 -672. 被引量:1
  • 4Kaplan AP, Greaves M. Pathogenesis of chronic urticaria [J]. Clin Exp Allergy, 2009, 39(6) :777 -787. 被引量:1
  • 5Miescher SM, Horn MP, Pachlopnik JM, et al. Natural anti-Fcepsilon- RIalpha autoantibodies isolated from healthy donors and hronic idiopathic urticaria patients reveal a restricted repertoire and autoreactivity on human basophils [ J ]. Hum Antibodies, 2001,10 ( 3-4 ) : 119 - 126. 被引量:1
  • 6Kikuehi Y, Kaplan A. A role for C5a in augmenting IgG dependent histamine release from basophils in chronic urticaria [ J ]. J Allergy Clin Immunol, 2002, 109 ( 1 ) : 114 - 118. 被引量:1
  • 7甘慧,杨军,孙萍,王全立.人类补体C3研究进展[J].国外医学(临床生物化学与检验学分册),2004,25(6):519-521. 被引量:26
  • 8Zamiri M, Jury SC, Dawe SR, et al. Reactivity to autologous serum skin test and relationship with complement levels in chronic idiopathic urticaria and angio-oedema[ J]. Clinical and Experimental Dermatology, 2009,34(5):587 -590. 被引量:1
  • 9Barnun S, Jones J, Ladner U, et al. Chronic complement C3 gene expression in the CNS of transgenic mice with as trocyte-targeted interleukin-6 expression [ J ]. GLIA, 1996, 18 ( 2 ) : 107 - 117. 被引量:1
  • 10Katz Y, Nadiv O, Papoport M, et al. IL-17 regulates gene expression and protein synthesis of the complement system, C3 and factor B, in skin fibroblasts[J]. Clin Exp hnmunol, 2000, 120( 1 ) :22 - 29. 被引量:1

二级参考文献13

  • 1Lambris JD, Reid KB, Volanakis JE. The evolution,structure,biology and pathophysiology of complement. Immunol Today, 1999, 20(5): 207-211. 被引量:1
  • 2Mollnes TE, Song WC, Lambris JD. Complement in inflammatory tissue damage and disease. Trends Immunol, 2002, 23(2): 61-64. 被引量:1
  • 3Sassi F, Bejaoui M, Ayed K. A congenital deficiency of the C3 fraction of complement. A familial study. Tunis Med,2003,81(5): 354-358. 被引量:1
  • 4Mizuno Y, Hara T. C3 deficiency. Ryoikibetsu Shokogun Shirizu,2000,32: 196-198. 被引量:1
  • 5Negi VS, Aggarwal A, Dayal R, et al. Complement degradation product C3d in urine: marker of lupus nephritis. J Rheumatol, 2000, 27(2): 380-383. 被引量:1
  • 6Ross TM, Xu Y, Bright RA, et al. C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge. Nat Immunol, 2000, 1(2): 127-131. 被引量:1
  • 7Abelseth TK, Stensvag K, Espelid S, et al. The spotted wolffish (Anarhichas minor Olafsen) complement component C3: isolation,characterisation and tissue distribution. Fish Shellfish Immunol, 2003, 15(1): 13-27. 被引量:1
  • 8Sahu A, Morikis D, Lambris JD. Compstatin,a peptide inhibitor of complement,exhibits species-specific binding to complement component C3. Mol Immunol, 2003, 39(10): 557-566. 被引量:1
  • 9Nagar B, Jones RG, Diefenbach RJ, et al. X-ray crystal structure of C3d: a C3 fragment and ligand for complement receptor 2. Science, 1998, 280(5367): 1277-1281. 被引量:1
  • 10Ekdahl KN, Nilsson B. Alterations in C3 activation and binding caused by phosphorylation by a casein kinase released from activated human platelets.J Immunol, 1999, 162(12): 7426-7433. 被引量:1

共引文献25

同被引文献151

引证文献11

二级引证文献106

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部